Skip to main content

Table 2 Clinicopahtological characteristics of patients grouped according to mGPS

From: The Glasgow Prognostic Score, an inflammation based prognostic score, predicts survival in patients with hepatocellular carcinoma

Variable

mGPS 0 (n = 119)

mGPS 1 (n = 11)

mGPS 2 (n = 20)

P-value

Age (years)

72 (43–91)

74 (64–82)

72 (51–79)

0.14

Sex (male/female)

80/39

10/1

16/4

0.16

HBsAg positive (%)

12 (10)

2 (18)

5 (25)

0.15

HCVAb positive (%)

76 (64)

1 (9)

7 (35)

0

AST (IU/l)

53 (14–240)

56 (17–238)

113 (13–384)

<0.0001

ALT (IU/l)

39 (10–202)

53 (14–190)

78 (8–157)

0.02

Total serum bilirubin (mg/dl)

0.8 (0.3-3.1)

0.7 (0.3-6.1)

1.6 (0.3-8.3)

0

Albumin (g/dl)

3.7 (2.1-5)

3.9 (3.5-4.6)

3.2 (2.2-3.4)

<0.0001

CRP (mg/dl)

0.1 (0.1-0.9)

1.5 (1.1-2.9)

2.6 (1.1-18.8)

<0.0001

WBC (cells/mm3 )

5200 (1800–14900)

5900 (3500–10600)

5800 (3900–12400)

0.07

Platelet count (104/mm3 )

13.2 (2.8-30.9)

25.3 (1.8-42.1)

17.3 (8.7-44.3)

0

Prothrombin time (%)

83 (38–100)

95 (74–100)

77 (45–97)

0.01

α-fetoprotein (ng/ml)

22 (1.9-59597)

77 (2–138011)

144 (1.7-280600)

0.05

Child-Pugh grade (A/B/C)

91/26/2

10/1/0

6/10/4

<0.0001

CLIP score (0/1/2/3)

41/43/24/11

3/0/3/5

0/7/1/12

<0.0001

JIS score (0/1/2/3)

18/43/41/17

0/4/3/4

0/1/6/13

<0.0001

BCLC score (0/A/B/C,D)

18/61/31/9

0/4/2/5

0/6/2/12

<0.0001

Tumor stage (І,ІІ,ІІІ,ІV)

21/52/41/5

0/4/3/4

1/4/4/11

<0.0001

Maximal tumor diameter (mm)

30 (7–200)

110 (40–150)

50 (10–130)

<0.0001

Tumor number (solitary/multiple)

66/53

6/5

5/15

0.04

Vascular invasion (absent/present)

114/5

8/3

13/7

<0.0001

Extrahepatic metastasis (absent/present)

117/2

10/1

17/3

0.01

  1. Abbreviaions: HBsAg = hepatitis B surface antigen; HCVAb = hepatitis C antibody; AST = aspartate aminotransferase; ALT = alanine aminotransferase.
  2. CRP = C-reactive protein; WBC = white blood cell count; ICG = indocyanine green dye retention rate at 15 minutes; CLIP = Cancer of the Liver Italian Program.
  3. JIS = Japan Integrated Staging score; BCLC = Barcelona Clinic Liver Cancer; GPS = Glasgow Prognostic Score.